|
Characteristic (n)
|
Category
|
n (%)
|
|---|
|
Sex (154)
|
Male
|
150 (97.4)
|
|
Female
|
4 (2.6)
|
|
Race (154)
|
White
|
142 (92.2)
|
|
Black
|
6 (3.9)
|
|
Other
|
6 (3.9)
|
|
Duration of PPI use (156)
|
0–2 months
|
48 (30.8)
|
|
2 months to 2 years
|
34 (21.8)
|
|
3–5 years
|
20 (12.8)
|
|
> 5 years
|
54 (34.6)
|
|
Name of current PPI (156)
|
Omeprazole
|
92 (58.9)
|
|
Pantoprazole
|
58 (37.2)
|
|
Lansoprazole
|
4 (2.6)
|
|
Esomeprazole
|
2 (1.3)
|
|
Interval of PPI (156)
|
Once a day
|
103 (66)
|
|
Twice a day
|
52 (33.3)
|
|
As needed
|
1 (0.6)
|
|
Route of PPI (156)
|
Oral
|
154 (98.7)
|
|
Intravenous
|
2 (1.3)
|
|
Medical provider who initiated the PPI (156)
|
Primary care physician
|
91 (58.3)
|
|
Internal medicine
|
47 (30.1)
|
|
Surgery
|
11 (7.1)
|
|
Gastroenterology
|
7 (4.5)
|
|
Setting where the PPI was started (156)
|
Outpatient
|
98 (62.8)
|
|
Non-ICU
|
53 (34)
|
|
ICU
|
5 (3.2)
|
- Mean age (standard deviation) = 70.9 years (9.3). Median length of hospital stay (interquartile range) = 11 days (13). PPI proton pump inhibitor, ICU intensive care unit
